Thus, high-grade tumor budding and expression by MICs of MMP-9, -11, -14, TIMP-1, or TIMP-2 were associated with a poor prognosis in all cases, whereas the association of low tumor budding count and the non-expression of either MMPs or TIMPs was associated with a better outcome (Figure 5). This evidence concerns the gene MMP9 and neoplasm.